Epithelix is one of the Short-listed Nominee for the 2006 Word Technology Award for Health and Medicine.

The World Technology Network (WTN) is a global meeting ground, a virtual think tank, and an elite club whose members are all focused on the business and science of bringing important emerging technologies of all types (from biotech to new materials, from IT to new energy sources) into reality. The WTN's membership is comprised of approximately 1000 members from more than 60 countries, judged by their peers to be the most innovative in the technology world.

• World Technology Network  

L'année de l'entreprise - Dossier sur les start-up romandes.

• PME Magazine/ Le Temps

Networking for the medical device & in vitro diagnostics industries. London. UK.

• Medical Innovation Forum  

Reduction of animal experimentations: Epithelix.

• Végi-info  

Innovative R&D Solutions for Respiratory Diseases and Chemical Testing. Ludovic Wiszniewski. Epithelix Sàrl. Alicante. Spain.

• Voir la présentation en PDF  

Ludovic Wiszniewski, (venture plan et venture training) et Jean-Paul Derouette (venture challenge) révolutionnent le paysage de la médecine fondamentale et de l’industrie chimique et pharmaceutique, en commercialisant des tissus épithéliaux humains cultivés in vitro et caractérisés par une remarquable longévité...

• Venturelab News  

Tissue engineering and ethics.

• Allianceinfo
  

Within the framework of the new European legislation on chemicals(REACH), Epithelix commercialize an alternative solution to the animal experimentation for long-term toxicity testing. Epithelix is mentioned in the review, The Economist. 

• The Economist (page 1)
• The Economist (page 2)
• The Economist (page 3)
  

Epithelix, winner (fourth position) of the Venture 2006 prize organized by ETH Zurich and McKinsey & Company.

• NZZ online
  

Epithelix sells human tissue cultures. The technology of the start-up makes it possible to reduce the animal experiments.

• Read the press release